EUVIMEDEUVIMED entdecken
Open Access

Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma

William A Hall iD, Jiahe Li, Y Nancy You iD, Marc J Gollub iD, Joseph R Grajo, Mark Rosen, Greg dePrisco, Greg Yothers iD, Jennifer A Dorth iD, Osama E Rahma iD, Marcia M Russell, Howard M Gross und 8 weitere

Journal of Clinical Oncology · 10.10.2023 · 41 (29) · 4643-4651

DOI: 10.1200/jco.22.02525 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.10.2023. Verfasst von William A Hall und 19 weiteren Autor:innen. Beteiligte Einrichtung: Froedtert and the Medical College of Wisconsin, Milwaukee, WI. Hauptthemen laut MEDLINE: Adenocarcinoma, Rectal Neoplasms. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Total neoadjuvant therapy (TNT) is a newly established standard treatment for rectal adenocarcinoma. Current methods to communicate magnitudes of regression during TNT are subjective and imprecise. Magnetic resonance tumor regression grade (MR-TRG) is an existing, but rarely used, regression grading system. Prospective validation of MR-TRG correlation with pathologic response in patients undergoing TNT is lacking. Utility of adding diffusion-weighted imaging to MR-TRG is also unknown. METHODS We conducted a multi-institutional prospective imaging substudy within NRG-GI002 (ClinicalTrials.gov identifier: NCT02921256 ) examining the ability of MR-based imaging to predict pathologic complete response (pCR) and correlate MR-TRG with the pathologic neoadjuvant response score (NAR). Serial MRIs were needed from 110 patients. Three radiologists independently, then collectively, reviewed each MRI for complete response (mriCR), which was tested for positive predictive value (PPV), negative predictive value (NPV), sensitivity, and specificity with pCR. MR-TRG was examined for association with the pathologic NAR score. All team members were blinded to pathologic data. RESULTS A total of 121 patients from 71 institutions met criteria: 28% were female (n = 34), 84% White (n = 101), and median age was 55 (24-78 years). Kappa scores for T- and N-stage after TNT were 0.38 and 0.88, reflecting fair agreement and near-perfect agreement, respectively. Calling an mriCR resulted in a kappa score of 0.82 after chemotherapy and 0.56 after TNT reflected near-perfect agreement and moderate agreement, respectively. MR-TRG scores were associated with pCR ( P < .01) and NAR ( P < .0001), PPV for pCR was 40% (95% CI, 26 to 53), and NPV was 84% (95% CI, 75 to 94). CONCLUSION MRI alone is a poor tool to distinguish pCR in rectal adenocarcinoma undergoing TNT. However, the MR-TRG score presents a now validated method, correlated with pathologic NAR, which can objectively measure regression magnitude during TNT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaRectal NeoplasmsFemaleHumansMaleMiddle AgedChemoradiotherapyMagnetic Resonance ImagingMagnetic Resonance SpectroscopyNeoadjuvant TherapyNeoplasm StagingTreatment OutcomeProspective Studies

Autor:innen und Institutionen

  • Froedtert and the Medical College of Wisconsin, Milwaukee, WI.
  • The University of Pittsburgh, Pittsburgh, PA.
  • University of Texas MD Anderson Cancer Center, Houston, TX.
  • Memorial Sloan Kettering Cancer Center, New York, NY.
  • University of Florida, Gainesville, FL.
  • University of Florida Health Cancer Center, Gainesville, FL.

ORCID-Profile: William A Hall, Y Nancy You, Marc J Gollub, Greg Yothers, Jennifer A Dorth, Osama E Rahma, Bryan A Faller, Theodore S Hong, Thomas J George

Förderung

  • NCI NIH HHS

Zitieren

APA

Hall, W. A., Li, J., You, Y. N., Gollub, M. J., Grajo, J. R., Rosen, M., dePrisco, G., Yothers, G., Dorth, J. A., Rahma, O. E., Russell, M. M., Gross, H. M., Jacobs, S. A., Faller, B. A., George, S., Al Baghdadi, T., Haddock, M. G., Valicenti, R., Hong, T. S., & George, T. J. (2023). Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma. Journal of Clinical Oncology, 41(29), 4643-4651. https://doi.org/10.1200/jco.22.02525

Vancouver

Hall WA, Li J, You YN, Gollub MJ, Grajo JR, Rosen M, et al. Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma. Journal of Clinical Oncology. 2023;41(29):4643-4651. doi:10.1200/jco.22.02525

BibTeX
@article{Hall2023,
  author = {Hall, William A and Li, Jiahe and You, Y Nancy and Gollub, Marc J and Grajo, Joseph R and Rosen, Mark and dePrisco, Greg and Yothers, Greg and Dorth, Jennifer A and Rahma, Osama E and Russell, Marcia M and Gross, Howard M and Jacobs, Samuel A and Faller, Bryan A and George, Sagila and Al Baghdadi, Tareq and Haddock, Michael G and Valicenti, Richard and Hong, Theodore S and George, Thomas J},
  title = {Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma},
  journal = {Journal of Clinical Oncology},
  year = {2023},
  volume = {41},
  number = {29},
  pages = {4643--4651},
  doi = {10.1200/jco.22.02525}
}
Kostenlos starten →